Tirzepatide (brand names Mounjaro and Zepbound) resulted in a decrease in 10.1 percent of body weight at six months and semaglutide (brand names Ozempic, Wegovy, and Rybelsus) resulted in a decrease of 5.8 percent of body weight at six months, according to a 2024 study in JAMA Internal Medicine
For recipes, real-life tips, and GLP-1 weight loss stories, join the GLPbase.com forum and share your journey with the community
Weight loss treatments are more affordable and accessible than ever in 2026, and Hers is one of the online platforms leading the charge
This medication aims to enhance metabolic function and appetite regulation, positioning it as a promising option for individuals struggling with obesity
How does the new Hers weight loss membership work
Can I combine Semaglutide GLP-1 with other treatments